Acadia Medical Hub

Scientific and Medical Information for Professionals

Our team is committed to providing U.S. healthcare professionals with accurate and current scientific information about Acadia products, and our research and development efforts to help address unmet medical needs.

Areas of Focus

Acadia is trailblazing breakthroughs in neuroscience to elevate life. Therapeutic areas of focus include Parkinson’s disease psychosis, Alzheimer’s disease psychosis, Rett syndrome, and negative symptoms of schizophrenia.

Parkinson’s Disease Psychosis (PDP)

PDP is typically characterized by hallucinations and delusions. Around 50% of patients with Parkinson’s disease may experience hallucinations and/or delusions over the course of their disease.

Learn More

Alzheimer’s Disease Psychosis (ADP)

Approximately 6 million people in the United States are living with Alzheimer’s disease, with this number projected to rise as the elderly population grows. Hallucinations and delusions associated with ADP affect around 30% of patients with AD dementia.

Learn More

Rett Syndrome (RTT)

RTT is a rare neurodevelopmental disorder that occurs primarily in females following apparently normal development for the first 6-18 months of life. RTT occurs worldwide in approximately one of every 10,000 to 15,000 female births (6,000 to 9,000 patients in the U.S.).

Learn More

Scientific Publications

In collaboration with key experts, Acadia is committed to scientific discovery for people with neurological conditions. Get to know our research in-depth by exploring our latest peer-reviewed scientific publications.

View Scientific Publications

Resources

We’re here to support medical professionals in their work. Click to explore our collection of resources, from info on clinical trials to our independent medical education grants.